MedPath

Prevalence of Kala-azar, Leprosy verses tuberculosis infectios among HIV Patients

Not Applicable
Completed
Conditions
Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Registration Number
CTRI/2017/08/009437
Lead Sponsor
ART centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
412
Inclusion Criteria

1. all the patients between age 6 to 60 would be included in the study.

Exclusion Criteria

1. Lost to follow up {LFU}

2. Death during study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prevalence of NTD, and Tb. co infectons among HIV patients enrolled from Jan 2016 to June 2017.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
CD4 cell count among NTD co infections and Tb. co infections and their comparative statistical analysisTimepoint: 16 months
© Copyright 2025. All Rights Reserved by MedPath